Newborn screening for vitamin B12 deficiency: Benefits outweigh harms
The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to ...
Investor's Business Daily on MSN7 天
Moderna Crashes After Slashing Its R&D Budget, Issuing Light Guidance
Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget and issued a light sales view.
BioSpace11 天
Moderna Slashes R&D Budget by $1.1B, Eyes 10 Approvals Through 2027
In an effort to build its commercial capacity, Moderna on Thursday announced it is lowering research and development spending ...
Moderna R&D Day Highlights Progress and Strategic Priorities
Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID ...
TMCnet11 天
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
Milan, Italy, 12 September 2024 – Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announces the appointment of ...
Moderna, Inc.: Moderna R&D Day Highlights Progress and Strategic Priorities
Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID combination vaccine for approval in 2024Announces positive ...
Pharmaceutical Technology24 天
Methylmalonic Acidemia drugs in development, 2024
The Methylmalonic Acidemia drugs in development market research report provides comprehensive information on the therapeutics under development for Methylmalonic Acidemia, complete with analysis by ...